Abstract
Appropriate management of the patient with localized adenocarcinoma of the prostate remains a controversial topic for various reasons. First, prostatic cancer occurs in an age group in which many other diseases affect the health of the host. Second, the biologic hazard presented by adenocarcinoma of the prostate can be exceedingly variable. This variability is dependent not simply on host factors, such as age and state of health, but also on factors indigenous to the tumor, such as degree of differentiation and metastatic potential. Finally, the majority of studies of the efficacy of one treatment modality versus another have consisted of uncontrolled analyses of patient survival comparative to historical controls alone; few randomized studies of treatment efficacy have been conducted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Babayan RK, deVere White R, Austen G Jr, Krane RJ, Feldman M, Olsson CA (1980) Benefits and complications of staging pelvic lymph node dissection in prostatic adenocarcinoma. Prostate 1: 345–349
Bagshaw MA (1969) Definitive radiotherapy in carcinoma of the prostate. JAMA 210: 326–327
Bagshaw MA (1984) Radiotherapy of prostatic cancer: Stanford University experience. In: Kurth KH, Debruyne FMJ, Schroeder FH, Splinter TAM, Wagener TDJ (eds) Progress and controversies in oncological urology. Alan R. Liss, New York, pp 493–512
Bagshaw MA, Ray GR, Cox RS (1985) Radiotherapy of prostatic carcinoma: long or short term efficacy. Urology [Suppl] 25: 17–23
Belt F, Shroeder FH (1972) Total perineal prostatectomy for carcinoma of the prostate. J Urol 107: 91–96
Carlton CE Jr, Hudgins PT, Guerriero WG, Scott R Jr (1975) Radiotherapy in the management of stage C carcinoma of the prostate. Trans Am Assoc GU Surg 67: 70–74
Cox JD, Stoffel TJ (1977) The significance of needle biopsy after irradiation for stage C adenocarcinoma of the prostate. Cancer 40: 156–160
Culp DS, Meyer JJ (1973) Radical prostatectomy in the treatment of prostatic cancer. Cancer 32: 1113–1118
Cupps RE, Utz DC, Fleming TR, Carson CC, Zincke H, Myers RP (1980) Definitive radiation therapy for prostatic carcinoma: Mayo Clinic experience. J Urol 124: 855–859
Donohue RF, Pfister RR, Weigel JW, Stonington OG (1977) Pelvic lymphadenectomy in stage A prostatic cancer. Urology 9: 273–275
Eggleston JC, Walsh PC (1985) Nerve sparing radical retropubic prostatectomy. Pathologic findings in the first 100 cases. J Urol 133: abstract 511
Freiha FS, Bagshaw MA (1984) Carcinoma of the prostate: results of post-irradiation biopsy. Prostate 5: 19–26
Golimbu M, Schinella R, Morales P, Kurusu S (1978) Stage A-2 prostatic cancer: clinical, pathological and prognostic difference from Al and B disease. J Urol 119: 618–622
Hilaris BS, Whitmore WF Jr, Batata MA, Grabstald H (1974) Radiation therapy and pelvic node dissection in the management of cancer of the prostate. Am J Roentgenol 121: 832–838
Hilaris BS, Whitmore WF Jr, Batata MA et al. (1977) Behavioral patterns of prostate adenocarcinoma following an I125 implant and pelvic lymph node dissection. Int J Radiat Oncol Biol Phys 2: 631–637
Jewett HJ, Bridge RW, Gray GF, Shelley WM (1968) The palpable nodule of prostatic cancer. Results 15 years after radical excision. JAMA 203: 403–406
Kiesling VJ, Friedman HI, McAninch JW, Nachtsheim DA, Nemeth TJ (1979) The ultrastructural changes of prostate adenocarcinoma following external beam radiation therapy. J Urol 122: 633–636
Kiesling VJ, McAninch JW, Goebel JL, Agee RE (1980) External beam radiotherapy for adenocarcinoma of the prostate. A clinical follow up. J Urol 124: 851–854
Kramer SA, Spahr J, Brendler CB, Glenn SF, Paulson DF (1980) Experience with Gleason’s histopathologic grading in prostate cancer. J Urol 124: 223–225
Kramer SA, Cline WA Jr Farnham R, Carson CG, Cox EB, Hinshaw W, Paulson DF (1981) Prognosis of patients with stage D-l prostatic adenocarcinoma. J Urol 125: 817–819
Kurth KH, Altwein JE, Hohenfellner R (1977) Follow up of irradiated carcinoma by aspiration biopsy. J Urol 117: 615–617
Kurup P, Kramer TS, Lee MS, Phillips R (1984) External beam irradiation of prostate cancer. Cancer 53: 37–43
Lindner A, deKernion JB, Smith RB, Katske FA (1983) Risk of urinary incontinence following radical prostatectomy. J Urol 129: 1007–1008
Mahan DE, Bruce AW, Manley PM, Fanchi L (1980) Immunohistochemical evaluation of prostatic cancer before and after radiotherapy. J Urol 124: 488–491
Olsson CA, deVere White R (1982) Health risk and management of prostate cancer. In: Paulson D (ed) Cancer treatment and research (GU cancer 1), vol 6. Martinus Nijhoff, Amsterdam, pp 121–142
Olsson CA, Tannenbaum M, Babayan R, O’Brien M, deVere White R (1982) Prediction of lymph node metastasis in adenocarcinoma of the prostate (abstr). Presented at Annual American Urological Association Annual Meeting, Kansas City
Olsson CA, Babayan R, deVere White R (1985) Surgical management of stage B or C prostatic carcinoma: radical surgery vs radiotherapy. Urology [Suppl] 25: 30–38
Paulson DF, Uro-Oncology Research Group (1979). The impact of current staging procedures in assessing disease extent of prostatic adenocarcinoma. J Urol 121: 300–302
Paulson DF, Lin GH, Hinshaw W, Stephani S, Uro-Oncology Research Group (1982) Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol 128: 502–504
Pistenma DA, Ray GR, Bagshaw MA (1976) The role of megavoltage radiation therapy in the treatment of prostatic carcinoma. Semin Oncol 3: 115–122
Ray GR, Bagshaw MA (1975) The role of radiation therapy in the definitive treatment of adenocarcinoma of the prostate. Ann Rev Med 26: 567–588
Ray GR, Bagshaw MA, Freiha FS (1984) External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy. J Urol 132: 926–930
Scardino PT, Delaune JM, Hoffman GS, Guerriero G, Carlton CE Jr (1982) The results and significance of prostatic biopsy after definitive radiation for carcinoma of the prostate (abstr). Presented at American Urological Association Annual Meeting, Kansas City, pp 194–195
Vernon SE, Williams WD (1983) Pre-treatment and post-treatment evaluation of prostatic adenocarcinoma for prostatic specific antigen by immunohistochemistry. J Urol 130: 95–98
Walsh PC (1980) Radical prostatectomy for the treatment of localized prostatic carcinoma. Urol Clin North Am 7: 583–591
Walsh PC, Donker PJ (1982) Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 128: 492–497
Walsh PC, Jewett JJ (1980) Radical surgery for prostate cancer. Cancer 45: 1906–1911
Whitmore WF Jr (1984) Interstitial I-125 implantation in the management of localized prostatic cancer. In: Kurth KH, Debruyne FMJ, Schroeder FH, Splinter TAM, Wagener TDJ (eds) Progress and controversies in oncological urology. Alan R. Liss, New York, pp 513–527
Whitmore WF Jr, Hilaris B, Grabstald H (1972) Retropubic implantation of iodine125 in the treatment of prostate cancer. J Urol 108: 918–920
Wilson CS, Dahl DS, Middleton RG (1977) Pelvic lymphadenectomy for the staging of apparently localized prostatic cancer. J Urol 117: 197–198
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Olsson, C.A. (1987). Management of Localized Adenocarcinoma of the Prostate. In: Bruce, A.W., Trachtenberg, J. (eds) Adenocarcinoma of the Prostate. Clinical Practice in Urology. Springer, London. https://doi.org/10.1007/978-1-4471-1398-0_8
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1398-0_8
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1400-0
Online ISBN: 978-1-4471-1398-0
eBook Packages: Springer Book Archive